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Abstract: The consortium of trillions of microorganisms that live inside the human gut are integral to
health. Little has been done to collate and characterize the microbiome of children. A systematic review
was undertaken to address this gap (PROSPERO ID: CRD42018109599). MEDLINE and EMBASE were
searched using the keywords: “healthy preadolescent children” and “gut microbiome” to 31 August
2018. Of the 815 journal articles, 42 met the inclusion criteria. The primary outcome was the relative
abundance of bacteria at the phylum, family, and genus taxonomic ranks. α-diversity, short chain fatty
acid concentrations, diet, 16S rRNA sequencing region, and geographical location were documented.
The preadolescent gut microbiome is dominated at the phylum level by Firmicutes (weighted overall
average relative abundance = 51.1%) and Bacteroidetes (36.0%); genus level by Bacteroides (16.0%),
Prevotella (8.69%), Faecalibacterium (7.51%), and Bifidobacterium (5.47%). Geographic location and 16S
rRNA sequencing region were independently associated with microbial proportions. There was
limited consensus between studies that reported α-diversity and short chain fatty acids. Broadly
speaking, participants from non-Western locations, who were less likely to follow a Westernized
dietary pattern, had higher α-diversity and SCFA concentrations. Confirmatory studies will increase
the understanding of the composition and functional capacity of the preadolescent gut microbiome.
Keywords: gut microbiome; gut microbiota; gut health; pediatrics; children; diet; short chain fatty
acid; SCFA; review
1. Introduction
The gut microbiota is a complex and dynamic environment containing 10–100 trillion
microorganisms represented by 1000 species [1–3] involved in numerous biological processes. They
assist in the breakdown of foods into metabolically and functionally important metabolites, such as
short chain fatty acids (SCFAs) [4] and vitamin K [5]. They also play a role in immune development
and several other areas crucial for our future health [6]. For example, a lack of Bifidobacteria during
infancy may result in the proliferation of pathogenic bacteria or a decrease in the nutritional status of
the infant [7]. Later in life, these microorganisms may play a role in the development or mediation
of several acute and chronic illnesses [8]. Although there are several studies of the microbiome in
‘normal’ or ‘healthy’ children, they often have small participant numbers and lack comparisons with
phenotypic data. Factors, including diet and environment, are significant modulators of the gut but
are seldom captured or considered in modelling. This systematic review aims to summarize the
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literature by characterizing the composition of the gut microbiota of preadolescent children, review the
impact of primer selection, and explore associations between diet, geographical location and SCFA
concentrations on community structure.
The main development of the microbiome occurs during the first few years of life and may even
begin before birth. Until recently, it was believed children were born with a sterile gut. However,
emerging evidence suggests otherwise, but newborn gut sterility continues to be controversial [9–12].
Following birth, many factors can influence the development of the new-born gut microbiome,
including method of delivery, exposure to antibiotics, and breastfeeding status [13–16]. Researchers
of one study found that infants received 27.7% of their bacteria from breast milk [15]. During those
first few months the most abundant bacteria of the infant microbiome are anaerobic bacteria, such as
Bacteroides, Lactobacillus, and Bifidobacterium [17–19]. These bacteria belong to the phyla Bacteroidetes,
Firmicutes and Actinobacteria, respectively, and along with Proteobacteria from breast milk, dominate
the microbiome during the first year of life [14,20]. Major diversification occurs between the ages of
4–6 months with the introduction of solid foods and continues until the child is 2–3 years old [21].
This coincides with an increase in the relative abundance of butyrate producing bacteria, including
bacteria of the families Ruminococcaceae and Lachnospiraceae, both of the which are from the phylum
Firmicutes [22–24]. Emergence of bacteria of the phylum Verrucomicrobia also occurs at around
two-years old [19]. Overall, findings suggest that a child’s gut microbiome begins to stabilize and form
an adult-like composition between two and five years [25,26]. However, this view is not universal, and
development of the microbiome may continue until puberty or later [27–29]. Environment and diet are
considered to be important factors that shape the microbiome over this childhood period.
Geographical region and dietary intake have previously been shown to independently influence
the microbial communities, with differences seen between American, Malawian, and Amerindian
children and adults [30]. This variation in microbial community was also shown in a study of African
and Italian children [31]. These differences may relate to diet; African children consumed a traditional
rural African diet (high fiber) whereas European children followed a Western diet (highly processed).
In a study of Thai children, conducted by Kisuse et al. [32], those living in an urban environment were
more likely to consume a high fat diet, have relatively more bacteria of the genera Bacteroides and less
Prevotella than rural children. Many other studies have documented the acute and continuing influence
of diet on the gut microbiome in children and adults [33–36]. Dietary fiber is particularly important.
The three main SCFAs are acetate, butyrate, and propionate, and along with the other SCFAs, are
end-products of dietary fiber fermentation by microorganisms in the colon [37]. These metabolites
play a positive role in numerous bodily processes, including pH homeostasis, appetite suppression,
immunity, and gut health [38,39].
In addition to diet and geography, the method used to assess the gut microbiome can also
contribute to differences observed. In studies of the microbiome, hypervariable region selection
influences the sequence data and therefore the subsequent microbial community structure. There are
nine hypervariable regions of the 16S rRNA gene [40]. In a comparative analysis of variability within
those nine regions of the 16S rRNA gene, Yang and colleagues [41] concluded that the best representation
of the full length gene was the V4-V6 regions, while V2 and V8 were the least reliable regions. In another
study that used a well characterized mock community, it was found that compared with V7-V8 and
V6-V8 regions, the V4 region showed the highest similarity to the taxonomic distribution of the
mock community [42]. In contrast, an older study suggested V1-V3 provide good coverage of the
bacterial community [43]. In addition to the variation caused by using different hypervariable regions,
longer sequence reads do not necessarily mean more accurate data as shorter reads have less length
heterogeneity biases and risk of chimera formation [44].
Previous reviews of the pediatric microbiome have focused on children with a disease or group of
diseases, such as inflammatory bowel disease, or have focused on an individual taxon or ratio, such
as the Firmicutes: Bacteroidetes ratio. To our knowledge, this will be the first review to look at the
pediatric gut microbiome in a healthy population. Furthermore, of the limited research in children,
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this age group is one that has been frequently overlooked, as noted by Derrien, et al. [45]. This review
aims to capture a snapshot of the healthy pediatric gut microbiome using relative abundance data, and
to better understand any associations with geographical location and region selected for sequencing
and diet. This review will also identify limitations of the current literature and make suggestions for
the direction of future research.
2. Materials and Methods
2.1. Search Strategy
The search strategy, determination of eligibility, extraction, and analysis for this systematic
review were all predetermined and included in PROSPERO protocol (ID: CRD42018109599). Preferred
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines [46] were
followed and a Flow Diagram and Checklist are attached as Supplementary Figure S1.
The search strategy aimed to find only published studies. Initially, a limited search of MEDLINE
and EMBASE was undertaken on the 20th of September 2018, followed by analysis of the text words
contained in the title and abstract. The reference lists of all identified full-text articles were searched
for additional studies. Human studies published in English between the 1st January 2000 and the 31st
August 2018 were considered for inclusion. Only studies published using next generation sequencing
and microarray technologies for bacterial composition identification were considered. Case-control
studies and studies of children at predetermined risk of disease were not included in this review.
Participants had to be healthy, which was defined as free from any diagnosed disease or illness. Those
who were overweight or obese were included, as overweight and obesity are classified as a risk factor
rather than a disease [47]. Studies with undernourished or malnourished children were excluded.
Keywords were: child * OR pediatric * OR infant OR toddler OR preadolescent OR boy * OR girl * OR
prepubescent AND gastrointestinal microbiome OR gastrointestinal microbiota OR gut microbiome
OR gut microbiota OR gut health OR gut flora.
2.2. Data Extraction
All search results were imported into reference management software Endnote Version 9 (Thomson
Reuters). Titles and abstracts were initially reviewed for eligibility. Remaining articles were
independently reviewed in full text versions by two of the authors, K.E.D. and C.T.C. Where there
was a difference of opinion, consensus was sought before moving to the next study. Studies were
included in data extraction phase if they met the following criteria: (1) clinical trial or cohort study;
(2) healthy children where the majority of children included in the study were aged 2 to 12 years
(determined by mean or median age of the cohort, depending on availability); and (3) employed
molecular technologies to characterize part or all of the gut microbiome.
K.E.D. extracted data from eligible studies with assistance from C.T.C. The following demographic
variables were extracted: cohort location, cohort name and/or study population, age, sex, sample
size, study design, and inclusion and exclusion criteria. Information regarding laboratory techniques
included hypervariable region sequenced, sequencing platform, and DNA extraction protocol. The
primary outcome variable was relative abundance of taxa at the phylum, family, and genus taxonomic
ranks. Data and taxonomic names were extracted as reported. Ideally, they would conform with
either the US National Center for Biotechnology Information (NCBI) or List of Prokaryotic names with
Standing in Nomenclature (LPSN) naming systems. Taxa that did not fit these criteria was adapted
to these norms, where possible. Exploratory, or secondary outcomes, included α-diversity, SCFA
concentration, and associations with diet. Data reported in text, figures and tables as ‘unknown’ was
either not reported by the author, reported as unknown by the author, or not classified.
For one of the papers identified in the search, the authors decided to group the raw data [28],
as significant effort would have been required to untangle multiple time points of microbiome data
and the intervention had no significant effect on community structure (unweighted and weighted
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UniFrac p > 0.05). Therefore, there were participants with more than one time point within one age
range, potentially weighting the range with their composition.
Additionally, taxa that were classified at different taxonomic ranks were grouped into their higher
or lower level taxonomic rank, depending on the analysis. For example, Asteroleplasma and uncultured
Mollicutes are part of the Tenericutes phylum and were therefore included in this phylum. For genus,
where one or more species were listed for an individual genus, the taxa were added and grouped into
their respective genus.
SCFA concentrations were converted to µmol/g feces to allow comparisons between studies. Total
SCFA concentrations were calculated (referred in-text as calculated total SCFA concentrations) by
the summation of acetate, propionate and butyrate concentrations. The ratio of acetate: propionate:
butyrate was also calculated.
2.3. Statistical Analyses
Relative abundance data were individually weighted according to the sample size of the relevant
cohort. Results in tables and figures represent these values. To reduce variance, observations with a
weighted average relative abundance of less than 0.05% at phylum rank, 0.5% at family rank, and 0.5%
at genus rank were separately grouped into ‘Other’ at their taxonomic rank. Only baseline microbiome
data are presented. At the phylum rank, test of the differences in relative abundance between groups
(geographic location, age, and 16S region) were conducted in SPSS Version 25, using the Kruskal–Wallis
test [48], and Bonferroni correction [49] was applied to minimize Type I error. Significance level was
set at 0.05. Firmicutes: Bacteroidetes ratios were calculated using raw abundance data.
Diversity is a measure of number, type and/or evenness of a taxon or group of taxa in an ecosystem,
in this case bacteria within the human gut. α-diversity and β-diversity analysis were performed
using PRIMER-e Version 7 using extracted data (Quest Research Ltd., Auckland, New Zealand).
To calculate α-diversity, data were square root transformed and then Shannon diversity was calculated.
The α-diversity values were normally distributed (Shapiro–Wilk test, p = 0.535) with no zero values and
therefore, a Euclidean distance matrix was created in preparation for PERMANOVA (equivalent to an
ANOVA [50]). For β-diversity analysis, missing data were replaced by zeros (required for dissimilarity
matrix). To calculate β-diversity, data were square root transformed and a Bray–Curtis dissimilarity
matrix produced. PERMANOVAs were run using Type III sum of squares and 99,999 permutations [50].
Where less than 500 unique permutations were completed, a Monte Carlo simulation was utilized in
the determination of the p-values.
3. Results
A total of 42 studies, which included more than 2000 participants, were included (Table 1). Relative
abundance data were not available for 14 of 42 studies [21,30,51–62]. Most studies were from Asia,
Europe, and North America, with 12 studies each. The average age of participants in each study ranged
from 2.0 to 11.3 years. Of the 42 studies identified, 18 (42.9%) reported phylum rank data, 10 (23.8%)
reported family rank data, and 19 (45.2%) reported genus rank data. Of the phylum rank studies, the
most sequenced hypervariable region was the V6 region (n = 7, 38.9%). Only one study sequenced the
whole 16S rRNA gene (5.56%). The review identified 13 phyla, 72 familiae, and 200 genera.
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Table 1. Participant characteristics in included studies.
First Author
Year [REF]
Cohort
Location
Study
Population Study Design Age Range
Number of
Participants
16S rRNA
Target Region
Sequencing
Platform Summary
Avershina 2014
[63] Norway
Healthy infants
(IMPACT
Cohort)
Longitudinal 2 years 39 V3-V4 454
The butyrate producing family
Lachnospiraceae dominated the microbiome
of the two-year-old children (46%).
Followed by unclassified Actinobacteria
and Faecalibacterium.
Berding 2018
[64] USA
Healthy
preadolescents Longitudinal 4–8 years 22 V3-V4 MiSeq
Baseline dietary patterns are associated
with temporal stability of microbiota over
a 6-month period
Bisanz 2014 [65] Tanzania
Healthy
children
exposed to
heavy metals
Longitudinal 6–10 years 40 V6 Ion torrent
Probiotic yoghurt did not significantly
impact community composition. Gut was
dominated by Prevotellaceae, similar to the
other African study (De Filippo et al. [31]).
Ringel-Kulka
2013 [66] USA
Healthy
children Cross-sectional 1–4 years 28 V1 and V6
HITChip
Microarray
Firmicutes dominated the gut microbiome
at a phylum rank. Clostridium cluster XIVa
was the most abundant taxon. Authors
suggest microbiota is not adult-like at
4 years.
Cheng 2016 [28] USA Healthychildren Longitudinal 1–5 years 28 As above As above
Bacterial diversity did not increase with
age. All age groups were dominated by
Firmicutes at the phylum. At genus rank,
it was Ruminococcus, Clostridium and
Bifidobacterium. The authors conclude that
at age five the microbiome is still
developing towards a stable adult-like
composition.
De Filippo 2010
[31]
Italy (EU),
Burkina Faso
(BF)
Healthy
children Cross-sectional 1–6 years 29 V5-V6 454
Significant difference in community
structure. BF gut dominated by genera
Prevotella and Xylanibacter. EU gut
dominated by genera Faecalibacterium and
Bacteroides.
De Filippo 2017
[67] As above As above Cross-sectional 2–8 years 37 As above As above
Burkina Faso rural children had a gut
dominated by bacteria of the Prevotellaceae
family (66.8%). This trended downwards
as the participants became less rural and
was even more extreme for the Italian
children, where the relative abundance of
Prevotellaceae was only 0.44%.
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Table 1. Cont.
First Author
Year [REF]
Cohort
Location
Study
Population Study Design Age Range
Number of
Participants
16S rRNA
Target Region
Sequencing
Platform Summary
Schloss 2014
[68] USA
Healthy
children Longitudinal 2–10 years 4 V3-V5; WGS 454
As others have concluded,
intra-individual variability is less than
inter-individual microbiome variability.
Ghosh 2014 [69] India Data of healthychildren only Cross-sectional 2.5–6 years 5 WGS only 454
Apparently healthy Indian children’s gut
microbiome were dominated at the
phylum rank by Bacteroidetes and
Firmicutes and at the genus rank by
Prevotella. This is similar to those in other
developing countries, such as Burkina
Faso [31] and Tanzania [65]
Hollister 2015
[70] USA
Healthy
preadolescents Cross-sectional 7–12 years 37 V3-V5; WGS HiSeq 2000
In 16S rRNA analysis the gut microbiome
was dominated at the genus rank by
Bacteroides, Faecalibacterium and Alistipes.
In the WGS subgroup analysis, Bacteroides,
Faecalibacterium, Bifidobacterium and
Alistipes dominated at the genus rank.
Jakobsson 2014
[19] Sweden Healthy infants Longitudinal 2 years 24 V3-V4 454
At two years old, the gut microbiome was
dominated at the phylum rank by
Firmicutes and at the genus rank by uncl.
Lachnospiraceae, Bacteroides and
Bifidobacterium. Similar to results from
Avershina et al. [63].
Chong 2015 [71] Malaysia Healthychildren Cross-section 7–12 years 61 V3-V5 454
Despite differences in hygiene practices
and socioeconomic status, Chinese and
Malays were not significantly different.
Orang Asli were significantly different to
other ethnicities.
Kisuse 2018 [32] Thailand Healthychildren Cross-sectional 9–11 years 45 V1-V2 MiSeq
Rural children followed a more traditional
plant-based diet and had higher SCFA
production and a functional gut reflecting
this. City of residence significantly
associated with community structure even
after adjustment for age and gender. At
phylum rank, the microbiome was
dominated by Bacteroidetes and
Firmicutes. At the genera rank, Bacteroides,
Prevotella and Faecalibacterium were the
most dominant.
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Table 1. Cont.
First Author
Year [REF]
Cohort
Location
Study
Population Study Design Age Range
Number of
Participants
16S rRNA
Target Region
Sequencing
Platform Summary
Koenig 2011 [25] USA Healthy child Longitudinal 1–2.5 1 V1-V2 454
Bacteroidetes and Firmicutes dominate
the child’s microbiome at from one year
onwards. This is associated with an
increase in SCFAs and an enrichment of
carbohydrate utilization genes. Results
suggest that the 2.5-y-old human gut
microbiome has many of the functional
attributes of the adult microbiome.
Lim 2015 [24] USA Healthychildren Longitudinal 2 years 8 V4 MiSeq
24-month microbiome was dominated at
the family rank by Lachnospiraceae and
Ruminococcaceae. Both of which contain
known butyrate producers.
Lin 2013 [72] Bangladesh,USA
Healthy
children Longitudinal 9–14 years 10 V1-V3 454
Prevotella and lactobacillus were higher in
NE children, as was vegetables. Both of
which were correlated. Prevotella was
higher in others following a traditional
plant-based diet [31,32,65].
López-Contreras
2018 [73] Mexico
Healthy
children Cross-sectional 6–12 years 138 V4 MiSeq
Both microbiomes were dominated at the
phylum rank by Bacteroidetes (67.5% in
normal weight children and 69.4% in
obese children) and Firmicutes (27.8% in
normal weight and 26% in obese children).
At the genus rank, the four most abundant
bacteria were Bacteroides (39.0%), Prevotella
(24.0%), unclassified Lachnospiraceae (7.2%)
and unclassified Ruminococcaceae (6.1%).
Nakayama 2015
[74]
China, Taiwan,
Japan,
Indonesia,
Thailand
Healthy
children Cross-sectional 7–11 years 303 V6-V8 454
Overall, at the phylum rank the
microbiome was dominated by Firmicutes
(61.98%) and at the genus rank by
Bifidobacterium, Faecalibacterium and
Bacteroides (overall average above 10%
each). Two Indonesian cities show highest
α-diversity and Japanese cities reported
lowest α-diversity.
Nakayama 2017
[75] Philippines
Healthy
preadolescents Cross-sectional 7–9 years 43 V6-V8 454
Baybay children’s microbiome was
dominated by the family Prevotellaceae,
whose diets had significantly less fat.
Ormoc children by the families
Ruminococcaceae and Lachnospiraceae.
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Table 1. Cont.
First Author
Year [REF]
Cohort
Location
Study
Population Study Design Age Range
Number of
Participants
16S rRNA
Target Region
Sequencing
Platform Summary
Nicolucci 2017
[76] Canada
Overweight or
obese children
(>85th BMI
percentile)
Longitudinal 7–12 years 42 V3 MiSeq
At a phylum rank, microbiomes were
dominated by Firmicutes (prebiotics
group = 68.6%, placebo group = 68%) and
Bacteroidetes (both 14.7%).
Riva 2017 [77] Italy Healthychildren Cross-sectional 9–16 years 78 V3-V4 MiSeq
At all three taxa ranks there was a clear
distinction in microbiota composition
between normal weight and obese
children. F:B ratio was significantly higher
in obese children. This is similar to other
studies examining body composition and
F:B ratio ([78,79]).
Smith-Brown
2016 [80] Australia
Healthy
preadolescents Cross-sectional 2–3 years 37 V6-V8 MiSeq
Correlations and UniFrac analyses
indicated that intake of several food
groups is associated with various genera
and microbial composition.
Smith-Brown
2018 [81] As above As above As above As above As above As above As above
Weighted UniFrac is associated with FFMI
z-scores in all participants but only
significant in boys (when stratified by
gender).
Hollister 2018
[82]
USA (Hispanic
children) Obese children Longitudinal 2–5 years 52 V1-V3 MiSeq
Despite significant weight loss in the
intervention group, limited shifts in
community composition were seen,
including no significant changes in
α-diversity.
Yassour 2016
[13] Finland
Healthy infants
(DIABIMMUNE
study)
Longitudinal 2–3 years 39 V4 16S: MiSeq;WGS: HiSeq
Antibiotic positive children had reported
greater instability between consecutive
samples. The microbiome of the whole
group was dominated at the family rank
at 24 to 36 months by Bacteroidaceae (42%),
Ruminococcaceae (17%) and Lachnospiraceae
(14%).
Zhou 2016 [83] China Healthy twins Cross-sectional 1–6 years 14 WGS HiSeq 2500
The genus Bacteroides dominated the gut
(36.6%), followed by Eubacterium (11.1%)
and Bifidobacterium (6.98%).
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Table 1. Cont.
First Author
Year [REF]
Cohort
Location
Study
Population Study Design Age Range
Number of
Participants
16S rRNA
Target Region
Sequencing
Platform Summary
Murugesan 2015
[84] Mexico
Healthy
children Cross-sectional 9–11 years 190 V3 Ion torrent
Normal weight and obese children had a
similar relative abundance of
Actinobacteria, Bacteroidetes and
Firmicutes, however, there were 2.5 times
more relative Proteobacteria in normal
weight children.
Monira 2011
[85] Bangladesh
Data of healthy
children only Cross-sectional 2–3 years 7 V5-V6 454
Prevotella and Bacteroides dominated the
microbiome of healthy Bangladeshi
children.
Sequencing platform: 454 = Roche 454 pyrosequencer; MiSeq = Illumina MiSeq; HiSeq = Illumina HiSeq. SCFA: short chain fatty acid; WGS: whole genome sequencing. Additional
information: for detailed age (study means were taken where group means were not available), participants in each group, see Table S12.
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3.1. Phylum Level Impact of Geographical Location, Age and 16S rRNA Region
Overall, at the phylum taxonomic rank, the microbiome was dominated by Firmicutes (weighted
overall average relative abundance = 51.1%), Bacteroidetes (36.0%), Actinobacteria (5.98%) and
Proteobacteria (2.93%). In addition to these major phyla, Verrucomicrobia (0.57%), Tenericutes (0.12%),
Fusobacteria (0.05%) and an unclassified portion (3.07%) were also detected (Table S1 and Figure 1).
There were lower proportions of Firmicutes in African (31.6%) and Central American children (35.7%)
compared to Western regions (Europe: 67.7% and North America: 69.0%). Firmicutes and Bacteroidetes
in European and Central American children were significantly different (p = 0.041, and p = 0.038,
respectively). In European and North American children, the Firmicutes: Bacteroidetes ratio was
greater than African and Central American children (3.21 and 3.88, respectively, compared to 0.57 and
0.61, respectively), with Asian children in between (Firmicutes: Bacteroidetes ratio of 2.23). Proportions
of Actinobacteria were significantly higher in Asian than Central American children (p = 0.035). Note
there are only a small number of African children (2.9%) compared to the other four populations.
Regarding diversity, Central American children had significantly lower α-diversity compared to the
other groups (North America p = 0.003, Asia p = 0.004, Africa p(Monte Carlo) = 0.033, Europe p(Monte
Carlo) = 0.015). For β-diversity there were similar findings, with Central American children being
significantly different to the other four groups. Africa also reported significantly different β-diversity
to the other four groups.
Figure 1. Weighted mean relative abundance (%) of bacteria by geographical location at the phylum
level. Other includes: Cyanobacteria, Lentisphaerae, Spirochaetes, Elusimicrobia, Synergistetes,
Euryarchaeota. Unknown refers to bacteria that were either not reported, unknown or unclassified.
Within age ranges, the gut microbiome was initially dominated by Firmicutes (73.8%, compared
to Bacteroidetes 13.0%) in children under 4 years old. In the following years, the relative abundances
of the two major phyla stabilized at comparable proportions (Table S2, Figure 2). A general decrease in
Actinobacteria was observed as children age, which is offset by a general increase in Proteobacteria
and not reported, unknown or unclassified bacteria. There were no significant differences in relative
abundances, α-diversity or β-diversity between the age groups.
How the microbial composition is detected, metagenomics or 16S rRNA amplicon, also impacts
the outcome. Of the 1294 participants (18 studies) that had phylum rank data, less than 1% had whole
genome data available (Table S3, Figure 3). Seven of the 18 studies sequenced regions that included the
V6 region whereas V4 and V1-3 was represented by five studies each. V6 region studies had significantly
higher proportions of Firmicutes and Actinobacteria than those who sequenced the V4 region (p = 0.004
and p = 0.001, respectively). V1-V3 region studies had significantly higher proportions of Proteobacteria
Nutrients 2020, 12, 16 11 of 24
than V4 and V6 region studies region (p < 0.001 and p = 0.007, respectively). α-diversity was not
significantly different (p = 0.355) by region. Whereas, β-diversity analysis indicated that V6 region
studies were significantly different to V1-V3 region studies (p = 0.009), V4 region (p = 0.007) and whole
genome data (p = 0.043). Whole genome was also significantly different to the other two variable
regions (V4 region p (Monte Carlo) = 0.041 and V6 region p (Monte Carlo) = 0.016).
Figure 2. Weighted mean relative abundance (%) of bacteria by ascending average age of the cohort
at the phylum level. Other includes: Cyanobacteria, Lentisphaerae, Spirochaetes, Elusimicrobia,
Synergistetes, Euryarchaeota. Unknown refers to bacteria that were either not reported, unknown
or unclassified.
Figure 3. Weighted mean relative abundance (%) of bacteria by 16S rRNA region at the phylum
level. Other includes: Cyanobacteria, Lentisphaerae, Spirochaetes, Elusimicrobia, Synergistetes,
Euryarchaeota. Unknown refers to bacteria that were either not reported, unknown or unclassified.
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3.2. Family Level Impact of Geographical Location, Age and 16S rRNA Region
At the family level, the gut was dominated by Bacteroidaceae (17.5%), Lachnospiraceae (16.8%),
Ruminococcaceae (13.9%), Prevotellaceae (12.1%) and Bifidobacteriaceae (5.09%). These taxa, along with the
seven others presented in the family tables (Tables S4–S6 and Figures S2–S4) represent almost 95.0% of
the classified bacteria. Due to the small numbers of studies reporting family rank data (n = 10), results
from this section should be interpreted with caution.
Within the geographical location analysis, the proportion of Prevotellaceae in African children
(46.5%) was almost four times higher than the average of 12.1% (Table S4 and Figure S2). It is important
to note there is only one African study with a small number of participants. Asian children had
relatively high proportions of Bifidobacteriaceae (12.0%) and Peptostreptococcaceae (1.96%) compared
to the overall averages (5.09% and 0.76%, respectively). Conversely, European children reported
higher proportions of Ruminococcaceae (27.8% compared to average of 13.9%), and lower proportions of
Prevotellaceae than the group average (1.96% compared to 12.1%).
The majority of the participants were from cohorts with a mean age of 8–10 years or 10+ year older
(90.9%) (Table S5 and Figure S3). There were no studies in the 6–8 years old range. The youngest group
(<4 years) had the greatest proportion of Bacteroidaceae (31.05%) and least amount of Prevotellaceae
(2.93%). In the 4–6 years old group, taking note of the relatively small proportion of participants in this
age range (3.20%), Prevotellaceae was almost three times higher than the overall weighted average of
the groups (33.4% compared to 12.1%). In the 8–10 year old group, proportions of Bifidobacteriaceae
were five-fold higher than the 10+ years group. Ruminococcaceae relative abundance was comparable
in the three age groups that reported this taxon.
Within the 16S rRNA region data (Table S6 and Figure S4), both V1-V3 region and whole genome
studies had relatively high proportions of not reported, unknown or unclassified bacteria (84.0% and
66.3%, respectively). Enterobacteriaceae proportions in the V1-V3 study were five times higher than their
closest group (4.07% compared to 0.81% in V6 region cohorts). Studies sequencing the V4 region had
low unknown bacteria (3.82%) compared to the other groups. V4 region studies were characterized
by relatively higher abundances of Bacteroidaceae, Prevotellaceae, Alicaligenaceae and Rikenellaceae than
overall populations. In comparison, V6 region studies were characterized by higher proportions of
Lachnospiraceae, Bifidobacteriaceae, Coriobacteriaceae and Peptostreptococcaceae (Table S6).
3.3. Genus Level Impact of Geographical Location, Age and 16S rRNA Region
At the genus taxonomic rank, the most dominant bacteria were Bacteroides (16.0%), Prevotella
(8.69%), Faecalibacterium (7.51%), Bifidobacterium (5.47%) and unclassified Lachnospiraceae (3.26%). These
taxa, along with the 19 others (Tables S7–S9), accounted for 89.0% of all classified bacteria. Overall,
29.8% of bacteria were not reported, unknown or unclassified. This was higher than the proportion of
unclassified bacteria at the family rank (23.4%) and more than nine times higher than the rate at the
phylum level (3.07%).
In African children (0.99% of participants), Prevotella dominated the gut (53.0%) and was higher
than any other population (Table S7 and Figure S5). Central American children were characterized
by the greatest relative proportions of Bacteroides (23.1%) as well as Prevotella (14.2%), unclassified
Lachnospiraceae (4.28%) and unclassified Ruminococcaceae (3.59%). Central American children (0.40%)
had low proportions of Bifidobacterium compared to the rest of the populations (ranged from 5.69–9.71%).
Bifidobacterium was not reported in the one African study. Faecalibacterium was comparable between all
populations (ranged from 4.0–9.0%, average = 7.5%).
Independent of the spike in the average weighted relative abundance of Bacteroides in cohorts
aged 4–6 years, there was a general increase in relative abundance with age (Table S8 and Figure S6).
This trend was similar for Prevotella and Dialister. It was reversed for Bifidobacterium, Ruminococcus
and Streptococcus. In young children (<4 years), Lachnospiraceae (9.77%), Bifidobacterium (8.26%),
unclassified Ruminococcaceae (6.06%), Clostridium XIVa (5.74%) and Clostridium (4.86%) characterized
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the gut. However, children >10 years had relatively higher Bacteroides (20.3%), Prevotella (10.99%),
unclassified Ruminococcaceae (3.79%) and Dialister (1.50%).
In congruence with family rank data, there were large proportions of not reported, unclassified or
unknown bacteria in the V1-V3 region data (67.9%) (Table S9 and Figure S7). Note that studies rarely
reported data at every taxonomic level and that is why there are differences in proportions of unknown
or unclassified data at family and genus ranks. Studies including the V4 region were dominated by
Bacteroides (27.1%), Prevotella (11.2%) and unclassified Lachnospiraceae (7.12%). In V6 region studies,
Bifidobacterium was the most relatively abundant bacteria (11.5%), followed by Faecalibacterium (9.59%),
Bacteroides (9.04%) and Prevotella (7.97%). Two whole genome studies followed a similar pattern to
the V6 region studies, however, participants in this group had higher proportions of Alistipes (8.15%),
Eubacterium (6.84%) and Dialister (3.28%) compared to the overall average (0.61%, 0.93% and 0.84%,
respectively). Blautia proportions are several times higher when the V6 region was analyzed (6.03%)
than all other groups.
3.4. α-Diversity as Reported by the Included Studies
Of the 42 studies, α-diversity was reported in 26 (61.9%) and five key measures were identified;
number of observed operational taxonomic units or species (S), Shannon Diversity (H’), Simpson
Diversity (λ), Inverse Simpson (1/λ), Species Richness (Chao1), and Phylogenetic Diversity (PD) Whole
Tree (Table S10). The most common α-diversity metric was Shannon Diversity (n = 17 studies), and
results ranged from 2.21 in 4–8-year-old North American children to 6.90 in 7–9-year-old Asian children.
Data may be transformed and/or normalized prior to diversity calculations, making between study
comparisons limited. However, comparisons within studies are still valid. In one study, age was
associated with significantly different Shannon Diversity and Inverse Simpson Diversity (although not
linear but u-shaped with age) [66]. However, in a follow up study using the same participants, age
was not associated with α-diversity [28]. In the comparison of geographically different populations,
three of the four studies reported significantly greater diversity in the more rural or less developed
populations [31,32,72]. The fourth study showed an increasing trend as the population became more
rural, however, it was not significant [67].
3.5. Comparison of SCFA Concentrations
Nine studies reported SCFA concentrations (21.4%) (Table S11). Large variations in SCFA
concentrations were observed. For example, calculated average total SCFA concentrations in
westernized populations ranged from 29.6 µmol/g [31] to 188.4 µmol/g [64]. There was also some
variation in the acetate:propionate: butyrate ratios reported for westernized population studies (2.7:0.9:1
to 8.3:2.5:1). Several of the studies reported quite different analytical methods for the analysis of the
SCFA. For example, De Filippo et al. [31,67] took advantage of the volatile nature of the SCFA and used
solid phase micro-extraction to extract the SCFA from headspace, followed by gas chromatography
mass spectrometry (GC–MS) to determine their concentrations. The use of isotopically labelled
SCFA as internal standards and a highly specific detector, mass spectrometry helped reduce potential
matrix effects and compensate for analyte loss during sample preparation/extraction respectively.
Keonig et al. [25] also used GC-MS and isotopically labelled SCFA as internal standards, but extracted
the SCFA into organic solvent, and chemically derivatized them before direct injection onto the GC.
Other studies used liquid chromatographic [62,84] and capillary electrophoretic methods [32,77].
Payne et al. [62] provided no details with respect to detection or the use of internal standards.
Murugesan et al. [84] using high performance liquid chromatography and Riva et al. [77] using capillary
electrophoresis both used a non-selective UV detector. UV detection is problematic, particularly at
low wavelengths, as coeluting interferences can contribute to the signal. Given the range of extraction
and detection methods used across the nine studies, comparisons across the studies is problematic.
In addition, two of the nine studies reported SCFA in millimolar; which are not comparable to the units,
umol/g, used in the other studies. Despite the variation in concentrations, there were observable trends
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within studies. African children reported significantly higher concentrations of total SCFA, acetate,
propionate, butyrate, and valerate than European children [31]. This association was explored further
by De Filippo et al. [67], which showed rural African populations had greater SCFA concentrations
than urban African populations. This difference in SCFA concentrations between rural and urban
environments was also reported for a Thai study of 45 children [32]. The Thai study also reported the
rural children had significantly higher butyrate concentrations (p < 0.05), but age and gender were not
predictors of SCFA concentrations [32].
3.6. Dietary Analysis
Less than half of the identified studies collected any dietary intake data (Table S12). Therefore,
results reported here are general observations from individual studies. Bacteroidetes was positively
associated with servings of fruit/day [64] but negatively with fat intake as a proportion of total
energy [75]. In contrast, Firmicutes was positively correlated with fat intake [75]. At the genus level, fat
intake ratio was negatively associated with Prevotella, Succinivibrio, and Catenibacterium and positively
associated with Bacteroides, Ruminococcus, and Blautia [75]. Bacteroides was also positively correlated
with servings of fruit/day [64]. Regarding measures of microbial diversity, servings of fruit/day and
intake of refined carbohydrates were negatively correlated with Chao Index and refined carbohydrates
was also negatively associated with PD whole tree [64]. Dairy serve intake was negatively associated
with Shannon Diversity and Chao Index [80]. Diet explains between 7% and 13% of observed microbial
variation [75,80].
4. Discussion
4.1. Overall Findings
Overall, the pediatric gut microbiome was characterized by high proportions of Firmicutes,
Bacteroidetes, Actinobacteria and Proteobacteria at the phylum rank. These were supported by minor
phyla such as Verrucomicrobia, Tenericutes and Fusobacteria. At the family rank, the dominant
bacteria included Bacteroidaceae, Lachnospiraceae, Ruminococcaceae, Prevotellaceae and Bifidobacteriaceae.
At the genus taxonomic rank, the dominant bacteria were Bacteroides, Prevotella, Faecalibacterium and
Bifidobacterium. Overall, there is good agreement between the dominant bacteria at the phylum, family
and genus ranks. Based on the data collated for this review, geographic location and 16S RNA region
sequenced were independent factors of community structure, while age was not.
4.2. 16S rRNA Sequencing Region and the Microbiome
Further investigation of β-diversity results suggests that the differences between cohorts are
more complicated than the three factors discussed. For example, of those who sequenced V1-V3
hypervariable regions, there was no significant difference in β-diversity by geographical location.
In contrast, all three geographical locations (Europe, North America, and Central America) were
significantly different to one another in studies that sequenced the V4 hypervariable region. Other
studies have independently identified geographical location as a factor in community structure, one
sequencing the V4 region [30] and the other the V1-V2 hypervariable region [86]. Children from Western
geographical areas had a similar microbiome structure at the phylum level. Both North American and
European children had high proportions of Firmicutes compared to the other geographical regions.
This similarity was also seen at the family rank, albeit in a less distinct way. The contrasts extend
to examining hypervariable region sequenced within geographical location. For example, within
North American studies, all hypervariable regions were significantly different to one another but
within Asian studies, the only significant difference in β-diversity was between V6 region studies and
whole genome studies (V4 region studies not present). As discussed, certain hypervariable regions, in
particular the V4 region, may provide more accurate representation of the true community [41,42].
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These findings further indicate that differences in study design influence community composition and
limit inter-study comparisons.
4.3. Diet, Geographical Location, SCFA, and the Microbiome
In addition to geographical location, other factors such as diet are important when considering the
composition and modulation of the microbiome. For example, the community composition of children
from Asian children reporting in Nakayama et al. [74], who were mainly from urban environments,
was similar to that of European and North American children reported in this review. This was
observed in the 8–10 year old category, where the majority of participants are from Asian countries,
with high proportions of Firmicutes. This is likely to be independent of sequencing region as multiple
regions were covered. It may be reflective of urban Asian populations transitioning from a traditional
plant-based diet to a more Westernized diet [87]. Lower fat and sugar consumption in the rural
compared to urban environments has been noted [32]. This transition is also reflected in the Firmicutes:
Bacteroidetes ratio, where children from Western regions had higher ratios than African and Central
American children. Asian children had a Firmicutes: Bacteroidetes ratio that was between Western and
African regions. Differences were also observed between Thai children: children from an urban setting
had a low ratio (0.624), while those in the rural group had a higher ratio (0.856), despite the rural
children consuming significantly more vegetables and rice and there being no significant difference in
overall energy intake [32]. These reported differences also depended on 16S rRNA region as the ratio
was lower in those who sequenced V1-V3 region compared to the other hypervariable regions. Several
authors have proposed that this ratio is associated with obesity status [88], with those having a higher
ratio being more likely to be overweight or obese according to animal studies [89], but the evidence is
inconclusive in human studies [90,91]. As our analysis indicate this ratio can merely be a reflection of
the 16S rRNA region sequenced so caution has to be taken when comparing across studies.
Despite fewer studies from less developed regions, α-diversity tended to be higher in African and
Central American children [92]. Rural status may not be the only geographical factor. Significantly
different α-diversity was seen in a study of 10 Asian cities, within five countries [74]. α-diversity has
been considered a proxy for health status with higher diversity being preferable [91], however, higher
α-diversity is not always associated with positive health status [93]. As a summary metric, α-diversity
does not take into consideration which bacteria are present, only the amount or distribution of the total
bacteria. Yatsunenko and colleagues [30] proposed that α-diversity increases over the lifespan, yet this
research suggests, at least in children, there is no such relationship.
The high proportions of Bacteroidetes in African and Central American children (Figure S5) are the
result of having more bacteria capable of fermenting fiber than Western populations namely Prevotella.
Bacteria within this genus are recognized for their ability to ferment fiber to produce SCFAs [94] and
are more abundant in populations who follow a traditional African high-fiber plant-based diet [31,67].
Despite the higher SCFA concentrations in African children when compared to western populations
within a study, there was a large variation between studies. For example, there was a five-fold
difference between the lowest and highest total calculated SCFAs in western populations. Although
the shortcomings in the study methodologies could not explain such a wide variation, concentrations
of SCFAs may be influenced by several factors, including volatility of the sample and potential loss of
analytes, extraction technique and platform used for analysis [95]. There was also variation in the SCFA
ratios, which typically exist in a 3:1:1 ratio in the gut [38], however these were closer to expectation
and may be better representations of the metabolic activity. For this reason, SCFA ratios should be
considered in future research, along with standardized analysis techniques and factors outside those
explored in this study (age and geography), such as diet [39,67,94,96,97].
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4.4. Association Between Age and the Microbiome
Age was not associated with changes in community structure, although there were trends in
specific taxa. Actinobacteria generally decreased with age and Proteobacteria increased. Bifidobacterium,
a dominant genus that sits within Actinobacteria, gave a similar trend, decreasing with age.
Bifidobacteria is one of the early colonizers of the newborn microbiome and is involved in the
breakdown of non-digestible carbohydrates [98]. It has been shown to be associated with several
positive health outcomes [99], including the prevention or treatment of cancer in animal models [100,101]
and the reduction of diarrhea episodes in infants [102,103]. Despite the quantity of research in the area,
the researchers identified no obvious reason for the decrease in relative proportions of Bifidobacteria
from early childhood into puberty and may be inversely related to proliferation of other bacteria, such
as Proteobacteria. This phylum contains some of the most well know pathogens, including the genera
Escherichia, Salmonella, Vibrio, and Helicobacter [104] and bacteria that may or may not be beneficial
such as Sutterella [105,106]. As noted by Derrien et al. [45], there is a paucity of research in pre-school
(3–6 years) and primary age (6–12 years) children. However, the results from this review are in line
with other research that suggests there are limited changes in α- and β-diversity after the early years of
life and the microbiome typically resembles an adult-like composition [14,45,107].
4.5. Limitations of the Current Research
One of the challenges of next generation sequencing research is producing data that accurately
represents the microbial community. This current review found that the selection of sequencing
region influences the community structure observed in children, which aligns with other research that
have examined the nine hypervariable regions [41]. Other factors can affect data prior to statistical
analysis thus rigorous and repeatable methodology, and choice of reference database is important
to ensure robust generalizable results. A comparison of data processing workflows found that
although diversity and relative abundances were different, the biological conclusions were similar,
suggesting generalizability of results [108]. A number of comparative studies have shown that bacteria
of lower relative abundance, which are as biologically important, are more likely to be classified
differently and the potential importance should not be discounted [109,110]. There are also a number
of other factors that influence microbiome data, including samples collection design, DNA extraction
protocols and specific workflow decisions, which have led to calls for developing standard workflow
practices [111–115].
Although beyond the scope of this review, an influential factor in taxonomic classification is
the database used. Advances in the field mean that recently published studies classified data with
updated databases, limiting direct comparisons between the studies. For example, several bacteria
were reclassified from Clostridium Cluster XIVa to a new genus, Blautia, in the late 2000s [116]. Similarly,
the genus, Xylanibacter, represented 20% of the ‘Other’ bacteria in De Filippo et al. [31]. The genus
is no longer listed in the NCBI database or Genome Taxonomy Database (GTDB). It is still listed by
the List of Prokaryotic Names (LPSN), however, the one species listed there, Xylanibacter oryzae, was
reclassified to the genus Prevotella as Prevotella oryzae in 2012 [117]. As the ability to isolate and identify
bacteria improves, and methods standardize, the ability to compare between studies should improve.
A substantial proportion of studies developed their own taxonomic metrics, including taxa ratios,
enterotypes, and metabolotypes. These were then compared with phenotypic data, with very few
studies also reporting raw unadjusted analyses. These findings were also not comparable to other
research. Similarly, α-diversity metrics were not calculated on the same type of data and therefore not
generalizable. Finally, none of the studies reporting SCFA concentration were compared to age, so it is
unclear if they vary with age.
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4.6. Strengths and Limitations of This Review
Strengths of this review include the broad initial search parameters and consideration of both
geographical regions and age groups. The review emphasizes the importance of primer selection
and highlights the necessary caution needed when comparing sequence data obtained by analyzing
different regions of the 16S rRNA gene. One limitation when comparing data using different workflows
and databases is that pipelines may produce different results limiting the generalizability. An additional
limitation of this study is that results were not separated by factors that could potentially influence
community structure within populations. This includes fecal collection methodology and participant
characteristics, such as body composition. Therefore, our results need to be interpreted with caution
and may not be generalizable to different populations. A standardized workflow in the future would
allow high-level individual age-related characteristics to be explored. However, collection method and
analysis of samples would still be a factor.
4.7. Consideration for Future Research
Future studies should consider analyzing the functional capacity of their participants gut
microbiome. Ideally by inclusion of metabolomics but alternatively consider a metagenomics approach
or use resources that can infer metabolic function, such as the bioinformatics software tool, Phylogenetic
Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) [118,119]. This would
start to progress research beyond associations and allow causative links to be explored [120]. More
consideration and measurement of confounders, such as diet, needs to be collected, and more research
in low- and middle-income countries is needed to help elucidate and validate differences between and
within geographic locations. Going beyond the analysis of the bacterial portion of the gut microbiome
will also help define the true composition of the preadolescent gut microbiome.
5. Conclusions
In conclusion, the preadolescent gut microbiome of children was dominated by Firmicutes and
Bacteroidetes, like the adult gut. Geographic location, age and 16S rRNA region are associated with
specific taxonomic characteristics emphasizing the importance of comparing studies from similar
geographic regions, and settings within this region, at similar ages using similar primers. There were
limitations in the way raw sequence data was processed, including database used for read classification,
presenting OTUs at different ranks, limiting the ability to compare between studies. This review also
highlighted the need for robust, well validated methods for analysis of SCFA. Future research with
larger studies and more phenotypic data are required to better understand the development and
composition of the pediatric gut and its importance for the future health of the child.
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